SIEN Stock Overview
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.
+ 1 more risk
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.17|
|52 Week High||US$9.14|
|52 Week Low||US$1.15|
|1 Month Change||-41.21%|
|3 Month Change||-64.00%|
|1 Year Change||-82.93%|
|3 Year Change||-83.52%|
|5 Year Change||-84.44%|
|Change since IPO||-93.39%|
Recent News & Updates
|SIEN||US Medical Equipment||US Market|
Return vs Industry: SIEN underperformed the US Medical Equipment industry which returned -15.6% over the past year.
Return vs Market: SIEN underperformed the US Market which returned -10.4% over the past year.
|SIEN Average Weekly Movement||12.2%|
|Medical Equipment Industry Average Movement||10.3%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: SIEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: SIEN's weekly volatility (12%) has been stable over the past year.
About the Company
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers.
Sientra Fundamentals Summary
|SIEN fundamental statistics|
Is SIEN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SIEN income statement (TTM)|
|Cost of Revenue||US$36.74m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.38|
|Net Profit Margin||-28.52%|
How did SIEN perform over the long term?See historical performance and comparison
Is Sientra undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SIEN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate SIEN's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: SIEN is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: SIEN is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SIEN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SIEN is overvalued based on its PB Ratio (2.9x) compared to the US Medical Equipment industry average (2.5x).
How is Sientra forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SIEN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SIEN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SIEN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SIEN's revenue (15.8% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: SIEN's revenue (15.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SIEN's Return on Equity is forecast to be high in 3 years time
How has Sientra performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SIEN is currently unprofitable.
Growing Profit Margin: SIEN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SIEN is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.
Accelerating Growth: Unable to compare SIEN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIEN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.4%).
Return on Equity
High ROE: SIEN has a negative Return on Equity (-95.24%), as it is currently unprofitable.
How is Sientra's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: SIEN's short term assets ($134.9M) exceed its short term liabilities ($84.7M).
Long Term Liabilities: SIEN's short term assets ($134.9M) exceed its long term liabilities ($82.1M).
Debt to Equity History and Analysis
Debt Level: SIEN's net debt to equity ratio (127%) is considered high.
Reducing Debt: SIEN's debt to equity ratio has increased from 0.07% to 282% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SIEN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SIEN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.5% each year
What is Sientra current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SIEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SIEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SIEN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SIEN's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SIEN has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ron Menezes (59 yo)
Mr. Ronald Menezes, also known as Ron, has been President and Chief Executive Officer of Sientra, Inc. since November 10, 2020 and serves as its Director. Mr. Menezes served as President and General Manage...
CEO Compensation Analysis
Compensation vs Market: Ron's total compensation ($USD1.10M) is above average for companies of similar size in the US market ($USD770.21K).
Compensation vs Earnings: Ron's compensation has been consistent with company performance over the past year.
Experienced Management: SIEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Experienced Board: SIEN's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.9%.
Sientra, Inc.'s employee growth, exchange listings and data sources
- Name: Sientra, Inc.
- Ticker: SIEN
- Exchange: NasdaqGS
- Founded: 2003
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: US$73.289m
- Shares outstanding: 62.64m
- Website: https://sientra.com
Number of Employees
- Sientra, Inc.
- 420 South Fairview Avenue
- Suite 200
- Santa Barbara
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/16 00:00|
|End of Day Share Price||2022/05/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.